Access
To read this story in full you will need to login or make a payment (see right).
Letter
Nature 441, 523-527 (25 May 2006) | doi:10.1038/nature04809; Received 15 February 2006; Accepted 13 April 2006; Published online 7 May 2006
Identification of a tumour suppressor network opposing nuclear Akt function
Lloyd C. Trotman1,2, Andrea Alimonti1,2, Pier Paolo Scaglioni1,3, Jason A. Koutcher4, Carlos Cordon-Cardo2 & Pier Paolo Pandolfi1,2
- Cancer Biology and Genetics Program,
- Department of Pathology,
- Department of Medicine,
- Departments of Medicine, Radiology and Medical Physics, Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Institute, 1275 York Avenue, New York, New York 10021, USA
Correspondence to: Pier Paolo Pandolfi1,2 Correspondence and requests for materials should be addressed to P.P.P. (Email: p-pandolfi@ski.mskcc.org).
Abstract
The proto-oncogene AKT (also known as PKB) is activated in many human cancers, mostly owing to loss of the PTEN tumour suppressor1. In such tumours, AKT becomes enriched at cell membranes where it is activated by phosphorylation. Yet many targets inhibited by phosphorylated AKT (for example, the FOXO transcription factors) are nuclear; it has remained unclear how relevant nuclear phosphorylated AKT (pAKT) function is for tumorigenesis. Here we show that the PMLtumour suppressor prevents cancer by inactivating pAKT inside the nucleus. We find in a mouse model that Pml loss markedly accelerates tumour onset, incidence and progression in Pten-heterozygous mutants, and leads to female sterility with features that recapitulate the phenotype of Foxo3a knockout mice2. We show that Pml deficiency on its own leads to tumorigenesis in the prostate, a tissue that is exquisitely sensitive to pAkt levels, and demonstrate that Pml specifically recruits the Akt phosphatase PP2a as well as pAkt into Pml nuclear bodies. Notably, we find that Pml-null cells are impaired in PP2a phosphatase activity towards Akt, and thus accumulate nuclear pAkt. As a consequence, the progressive reduction in Pml dose leads to inactivation of Foxo3a-mediated transcription of proapoptotic Bim and the cell cycle inhibitor p27kip1. Our results demonstrate that Pml orchestrates a nuclear tumour suppressor network for inactivation of nuclear pAkt, and thus highlight the importance of AKT compartmentalization in human cancer pathogenesis and treatment.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomasNature Medicine Technical Report (01 Jun 2007)
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomasNature Medicine Technical Report
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesisNature Letters to Editor (04 Aug 2005)
Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesisThe EMBO Journal Article
See all 24 matches for Research